Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Active Clonidine and Active ASA	2,499
Overall Study	STARTED	Active Clonidine and Placebo ASA	2,510
Overall Study	STARTED	Placebo Clonidine and Active ASA	2,499
Overall Study	STARTED	Placebo Clonidine and Placebo ASA	2,502
Overall Study	COMPLETED	Active Clonidine and Active ASA	2,488
Overall Study	COMPLETED	Active Clonidine and Placebo ASA	2,498
Overall Study	COMPLETED	Placebo Clonidine and Active ASA	2,488
Overall Study	COMPLETED	Placebo Clonidine and Placebo ASA	2,489
Overall Study	NOT COMPLETED	Active Clonidine and Active ASA	11
Overall Study	NOT COMPLETED	Active Clonidine and Placebo ASA	12
Overall Study	NOT COMPLETED	Placebo Clonidine and Active ASA	11
Overall Study	NOT COMPLETED	Placebo Clonidine and Placebo ASA	13

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01082874/flow